Froylan Portillo

403 posts

Froylan Portillo banner
Froylan Portillo

Froylan Portillo

@froylo

Cuack-Cuack

Everywhere Katılım Haziran 2009
1K Takip Edilen208 Takipçiler
Froylan Portillo retweetledi
DrThomasCuisset
DrThomasCuisset@CuissetDr·
#EuroPCR 2024 Major LBT – LANDMARK Previous head-to-head comparisons of new THVs with established devices confirmed no class effect of clinical benefits after #TAVI with inferior safety & efficacy for some of them. Validation of MyVal non-inferiority to the most widely used balloon-expandable and self-expandable platforms is therefore significant.
English
2
32
61
5.5K
Froylan Portillo retweetledi
Sergio Pérez
Sergio Pérez@SChecoPerez·
Sorry 😂🤣🤣🤣🤣🤣
English
4.6K
19.4K
134.6K
19.7M
Froylan Portillo retweetledi
AlphaFox
AlphaFox@alphafox·
This old guy is hilarious!! 💀
English
1K
23.5K
171.4K
6.3M
Froylan Portillo retweetledi
Mr. Lotario
Mr. Lotario@MrLotario·
Carlos estudiaba sociología, tenía una esposa llamada Sandra con quien acababa de tener a Rodrigo, su primer hijo, pero como no toleraba el llanto del bebé, se salía de casa todo el día y se la pasaba haciendo paros, hasta que un 14 de febrero de 1984, cupido hizo de las suyas...
Mr. Lotario tweet media
Español
789
6.9K
13.3K
1.5M
Froylan Portillo retweetledi
Luis Antonio Espino
Luis Antonio Espino@luisantespino·
La larga lista de iniciativas, reformas, ocurrencias y deseos populistas que ha dado a conocer AMLO es LA MADRE DE TODOS LOS DISTRACTORES. Estamos ante una OFENSIVA PROPAGANDÍSTICA muy agresiva. Hilo para explicar cómo funciona. 👇
Español
111
2.2K
4.6K
435.8K
Froylan Portillo retweetledi
The Culturist
The Culturist@the_culturist_·
10 Van Gogh masterpieces that inspired iconic movies scenes (thread): 1. “Wheatfield with Crows” // “Dreams”, directed by Akira Kurosawa
The Culturist tweet media
English
146
2.6K
20.6K
2.6M
Froylan Portillo retweetledi
Davide Capodanno
Davide Capodanno@DFCapodanno·
Where are we with drug-coated balloons (DCB) in PCI? Five thoughts. 1) The use of DCB in patients with in-stent restenosis, especially of a bare metal stent, is well established and evidence-based (now also in the US). 2) Conversely, DCB use in de novo disease lacks compelling clinical trial data. Use in small vessels and diffuse pattern disease is the most promising indication to date. Results of two ambitious trials (SELUTION De Novo AND TRANSFORM II) will define the role of DCBs in de novo disease going forward. 3) Growing experience with short DAPT and DES limits added value of DCB angioplasty in high bleeding risk patients. 4) The good performance of current generation DES in acute coronary syndromes questions the unmet need for this indication. 5) Robust data for DCB use in bifurcation PCI, where the provisional approach is dominant, is lacking.
Davide Capodanno tweet mediaDavide Capodanno tweet mediaDavide Capodanno tweet mediaDavide Capodanno tweet media
English
13
137
387
33.3K
Froylan Portillo retweetledi
Davide Capodanno
Davide Capodanno@DFCapodanno·
Factor XI (FXI) has recently emerged as a pivotal contributor to intraluminal thrombus formation and growth, playing a limited role in sealing vessel wall injuries. Nevertheless, the halt of the OCEANIC-AF trial has raised uncertainties about the future of this class. As frequently observed in cardiology, there is a risk of transitioning from excess enthusiasm to excess pessimism. Various compounds inhibiting FXI have undergone design, testing, and progression to phase 2 clinical trials, demonstrating a generally favorable safety and tolerability profile. However, validation through large-scale phase 3 trials with sufficient power to assess both safety and efficacy outcomes is needed. This review comprehensively examines FXI inhibitors, delving into individual classes, exploring their pharmacological properties, evaluating the latest evidence from randomized trials (including OCEANIC-AF) and offering insights into future perspectives. academic.oup.com/ehjcvp/advance…
Davide Capodanno tweet media
English
0
51
116
15K
Froylan Portillo retweetledi
Gregg W. Stone MD
Gregg W. Stone MD@GreggWStone·
PROSPECT II published in Lancet. We can identify vulnerable plaques and pts before events with NIRS-IVUS! Link to free download for 50 days. authors.elsevier.com/c/1cjWX_3CjG7l… Next: Definitive therapy trials.
Gregg W. Stone MD tweet mediaGregg W. Stone MD tweet mediaGregg W. Stone MD tweet media
English
11
85
241
0
Froylan Portillo
Froylan Portillo@froylo·
@Uber_MEX hola Uber, perdí un equipo médico en un Uber, pero no me da opción de llamar al conductor, me dicen que van a contactar pero no lo han hecho, en qué número puedo hablar con un asesor personalmente?? Las opciones de la app ninguna me deja hablar con alguien. Ayuda!!
Español
0
0
0
22
Claudia Sheinbaum Pardo
Claudia Sheinbaum Pardo@Claudiashein·
De camino a Mexicali paramos en el mirador de “La Rumorosa” con @MarinadelPilar. Vamos como dice mi compañera gobernadora: con el corazón por delante.
Claudia Sheinbaum Pardo tweet media
Español
1.6K
611
2.2K
582.2K
INJUVE CIUDAD DE MÉXICO
INJUVE CIUDAD DE MÉXICO@InjuveCDMX·
Como cada domingo, nos encontramos con el Paseo Dominical, #MuéveteEnBici en la 📍Glorieta del Ahuehuete para disfrutar de #LaCiudadQueLoTieneTodo y el préstamo de bicis que realiza el Instituto de 🕣8 a 14 hrs.👋🏻 #LosJóvenesUnenAlBarrio por el bienestar.✌🏻
INJUVE CIUDAD DE MÉXICO tweet mediaINJUVE CIUDAD DE MÉXICO tweet mediaINJUVE CIUDAD DE MÉXICO tweet mediaINJUVE CIUDAD DE MÉXICO tweet media
Español
2
10
30
3.7K